Heather A. Iocca

1.4k total citations
20 papers, 973 citations indexed

About

Heather A. Iocca is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Heather A. Iocca has authored 20 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Heather A. Iocca's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Immune Response and Inflammation (3 papers) and Hemophilia Treatment and Research (3 papers). Heather A. Iocca is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Immune Response and Inflammation (3 papers) and Hemophilia Treatment and Research (3 papers). Heather A. Iocca collaborates with scholars based in United States, Germany and France. Heather A. Iocca's co-authors include Jenny P.‐Y. Ting, Denis Gris, Zhengmao Ye, Haitao Wen, Monika Schneider, Pavel Gris, Robin R. Craven, Max T. Huang, Stephen D. Miller and Arrel D. Toews and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Heather A. Iocca

19 papers receiving 954 citations

Peers

Heather A. Iocca
Sarah C. Starossom United States
Ross C. Gruber United States
Sandrine Pouly Switzerland
Shafiuddin Siddiqui United States
Thaddeus Carlson United States
Sarah C. Starossom United States
Heather A. Iocca
Citations per year, relative to Heather A. Iocca Heather A. Iocca (= 1×) peers Sarah C. Starossom

Countries citing papers authored by Heather A. Iocca

Since Specialization
Citations

This map shows the geographic impact of Heather A. Iocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather A. Iocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather A. Iocca more than expected).

Fields of papers citing papers by Heather A. Iocca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather A. Iocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather A. Iocca. The network helps show where Heather A. Iocca may publish in the future.

Co-authorship network of co-authors of Heather A. Iocca

This figure shows the co-authorship network connecting the top 25 collaborators of Heather A. Iocca. A scholar is included among the top collaborators of Heather A. Iocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather A. Iocca. Heather A. Iocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farkas, Henriette, Jonny Peter, Marcin Stobiecki, et al.. (2025). Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema. Annals of Allergy Asthma & Immunology. 135(3). 311–319.e6. 1 indexed citations
2.
Bourgoin‐Heck, M., Mauro Cancian, William Yang, et al.. (2025). Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years. Annals of Allergy Asthma & Immunology. 135(6). 681–688.e3. 1 indexed citations
3.
Wedner, H. James, Emel Aygören‐Pürsün, Jonathan A. Bernstein, et al.. (2021). Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2305–2314.e4. 35 indexed citations
4.
Anderson, John, Rémi Gagnon, Jessica Best, et al.. (2021). Reduction in Attacks in Hereditary Angioedema (HAE) With Berotralstat is Consistent Regardless of Prior Prophylactic Treatment: A Subgroup Analysis of the Phase 3 APeX-2 Trial. Journal of Allergy and Clinical Immunology. 147(2). AB23–AB23. 1 indexed citations
5.
6.
Gower, Richard, Paula J. Busse, Jessica Best, et al.. (2021). Berotralstat Reduces Use of On-demand Medication in Hereditary Angioedema (HAE) Patients Previously Treated with Prophylactic Therapies. Journal of Allergy and Clinical Immunology. 147(2). AB146–AB146. 1 indexed citations
7.
Wedner, H. James, Bruce L. Zuraw, Timothy Craig, et al.. (2020). D102 BEROTRALSTAT REDUCES ATTACKS IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE): APEX-2 TRIAL 48 WEEK RESULTS. Annals of Allergy Asthma & Immunology. 125(5). S14–S14. 2 indexed citations
8.
Jacobs, Joshua, Emel Aygören‐Pürsün, Karl Sitz, et al.. (2020). P165 BEROTRALSTAT POSITIVELY IMPACTS PATIENT-REPORTED SATISFACTION: RESULTS FROM THE PHASE 3 APEX-2 TRIAL. Annals of Allergy Asthma & Immunology. 125(5). S25–S25. 1 indexed citations
9.
Johnston, Douglas, William R. Lumry, Aleena Banerji, et al.. (2020). Gastrointestinal (GI) Adverse Events (AEs) Observed With Berotralstat (BCX7353) Treatment for Hereditary Angioedema (HAE) are Primarily Mild, Self-limited, and Diminish with Time on Treatment. Journal of Allergy and Clinical Immunology. 145(2). AB102–AB102. 3 indexed citations
10.
Johnston, D., Aleena Banerji, Marc A. Riedl, et al.. (2020). P154 BEROTRALSTAT IMPROVES PATIENT-REPORTED QUALITY OF LIFE THROUGH 48 WEEKS IN THE PHASE 3 APEX-2 TRIAL. Annals of Allergy Asthma & Immunology. 125(5). S22–S22. 3 indexed citations
11.
Riedl, Marc A., William R. Lumry, Aleena Banerji, et al.. (2019). P154 SAFETY AND TOLERABILITY OF ONCE-DAILY ORAL KALLIKREIN INHIBITOR BCX7353 IN PHASE 3 APEX-2 HAE STUDY. Annals of Allergy Asthma & Immunology. 123(5). S28–S29. 3 indexed citations
12.
Zuraw, Bruce L., William R. Lumry, A. K. Banerji, et al.. (2019). P150 ORAL PROPHYLAXIS WITH BCX7353 REDUCES HAE ATTACK RATES AND IS WELL-TOLERATED: APEX-2 STUDY RESULTS. Annals of Allergy Asthma & Immunology. 123(5). S27–S27. 1 indexed citations
13.
Jha, Sushmita, W. June Brickey, Heather A. Iocca, et al.. (2010). The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18. Journal of Neuroscience. 30(47). 15811–15820. 266 indexed citations
14.
Gris, Denis, Zhengmao Ye, Heather A. Iocca, et al.. (2010). NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses. The Journal of Immunology. 185(2). 974–981. 346 indexed citations
15.
Iocca, Heather A., Sheila R. Plant, Ying Wang, et al.. (2008). TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. Journal of Neuroimmunology. 194(1-2). 97–106. 26 indexed citations
16.
O’Connor, Brian P., So-Young Eun, Zhengmao Ye, et al.. (2008). Semaphorin 6D regulates the late phase of CD4 + T cell primary immune responses. Proceedings of the National Academy of Sciences. 105(35). 13015–13020. 51 indexed citations
17.
Plant, Sheila R., Heather A. Iocca, Ying Wang, et al.. (2007). Lymphotoxin β Receptor (LtβR): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using LtβR–Ig Protein. Journal of Neuroscience. 27(28). 7429–7437. 41 indexed citations
18.
Taxman, Debra J., Jinghua Zhang, Catherine M. Champagne, et al.. (2006). Cutting Edge: ASC Mediates the Induction of Multiple Cytokines by Porphyromonas gingivalis via Caspase-1-Dependent and -Independent Pathways. The Journal of Immunology. 177(7). 4252–4256. 69 indexed citations
19.
Livingstone, Laura R., Jinghua Zhang, Brian J. Conti, et al.. (2006). Criteria for effective design, construction, and gene knockdown by shRNA vectors. BMC Biotechnology. 6(1). 7–7. 103 indexed citations
20.
Iocca, Heather A. & Harriet C. Isom. (2003). Tumor Necrosis Factor-α Acts as a Complete Mitogen for Primary Rat Hepatocytes. American Journal Of Pathology. 163(2). 465–476. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026